Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Nearly half of all states have an adult obesity prevalence of 35% or higher, new CDC data show.
Ozempic and related medications are changing how ordinary people as well as medical experts think about obesity.
New research by Dana-Farber scientists looks at elevated body mass index and chemotherapy for acute lymphoblastic leukemia (ALL).
Lean people had a higher mortality rate despite experiencing fewer metabolic problems.
GLP-1 analog medications improved the functionality of cancer-fighting natural killer cells.
Competition to claim a market has triggered a wave of advertising that has provoked the concern of regulators and doctors worldwide.
BMI may not be the best way to assess health risks linked to excess weight.
Most outcomes were similar in lean and heavy people with fatty liver disease, but the lean group had higher liver-related mortality.
Physical activity was associated with greater gut bacteria diversity and reduced inflammation in people with colon cancer.
Some 20% of those with NAFLD also showed signs of liver fibrosis.
The weight-to-height ratio, never meant as a diagnostic tool, is used to determine insurance coverage of weight loss therapies.
Alcohol consumption guidelines don’t take into account the greater risk associated with body weight.
Type 2 diabetes is more common among Black Americans and Latinos. Diabetes Alert Day highlights the seriousness and risks.
The long-acting injectable regimen suppressed HIV in more than 90% of study participants, including those with obesity.
With every centimeter increase in waist circumference, the risk of severe fibrosis rose by 5%.
The body’s ability to remove and store fat declines with age.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.